APOP stock: buy or sell?
February 14th, 2020
Cellect Biotechnology Ltd., a biotechnology company, focuses on developing technologies for the functional selection of stem cells in the field of regenerative medicine and stem cell therapies in Israel.
Should I buy APOP stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Cellect Bio stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Cellect Bio stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for APOP stock for the last 30 days.
APOP stock analysis
Cellect Biotechnology declined an ugly -0.43% and closed at $2.32.
Cellect Bio shares declined -0.43% to $2.32 on Feb/14. Since last December when SMA50d and SMA100d crossed up, APOP price slipped $-0.02 per share (-0.85%).
Shares of Cellect Biotechnology ended this week at $2.32 and remained constant a tight 0.00%. Early January APOP boosted an amazing 20.51% in just one week. Late January APOP plummed a dreadful -10.13% in just one week.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $6.89 resistance.
APOP stock price history
APOP stock went public on August 1st, 2016 with a price of $26.251. Since then, APOP stock lost a -91.20%, with a yearly average of -30.40%.
1: Adjusted price after possible price splits or reverse-splits.
APOP stock historical price chart
APOP stock reached 52-week highs on January 7th at $6.89, and all-time highs 2018-01-04 with a price of 67.5.
APOP stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' APOP stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price prediction for Cellect Bio stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareSince March, when Cellect Biotechnology published its last earnings report, it . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to , last anual turnover report draw of to M USD. When comparing vs , , profit margin (that is, the net income divided by revenues) a to .
Quarterly financial resultsReported quarter earnings marked $-3.75 M with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Cellect Biotechnology sales marked a tight move and remained steady a nan%. Looking back to recent quarterly results, Cellect Biotechnology posted 7 negative quarters in a row.
Cellect Bio ownershipWhen you are planning to buy shares of a stock, it's always worth to have a look its ownership structure.
Cellect Biotechnology shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 54.73% of all shares.
In case of Cellect Biotechnology stock, 0.00% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for APOP stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Cellect Bio:
|Market cap||$1.0 M|
|Total shares||0.4 M|
|Float shares||1.5 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||54.7%|
|Shares in short selling||0.0%|
|Friday, February 14th, 2020|
|Day range||$2.26 - $2.38|
|Average true range||$0.15|
|50d mov avg||$2.51|
|100d mov avg||$2.49|
|200d mov avg||$2.69|
Cellect Bio performanceTo measure stock performance is always good to compare with competitors or related stocks. For Cellect Bio, the benchmark is made against .